🚀 VC round data is live in beta, check it out!

Ashland Valuation Multiples

Discover revenue and EBITDA valuation multiples for Ashland and similar public comparables like Saudi Kayan, Huntsman, Quaker Houghton, Saudi Industrial Investment Group and more.

Ashland Overview

About Ashland

Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.


Founded

2016

HQ

United States

Employees

2.9K

Sectors

Financials (LTM)

Revenue: $2B
EBITDA: $396M

EV

$4B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Ashland Financials

Ashland reported last 12-month revenue of $2B and EBITDA of $396M.

In the same LTM period, Ashland generated $610M in gross profit, $396M in EBITDA, and $164M in net income.

Revenue (LTM)


Ashland P&L

In the most recent fiscal year, Ashland reported revenue of $2B and EBITDA of ($511M).

Ashland is unprofitable as of last fiscal year, with gross margin of 30%, EBITDA margin of (28%), and net margin of (46%).

See analyst estimates for Ashland
LTMLast FY202320242025202620272028
Revenue$2B$2B$2B$2B$2B
Gross Profit$610M$549M$656M$601M$549M
Gross Margin33%30%30%29%30%
EBITDA$396M($511M)$419M$100M($511M)
EBITDA Margin22%(28%)19%5%(28%)
EBIT Margin11%5%6%4%5%
Net Profit$164M($845M)$176M($85M)($845M)
Net Margin9%(46%)8%(4%)(46%)
Net Debt—$1B———

Financial data powered by Morningstar, Inc.

Ashland Stock Performance

Ashland has current market cap of $2B, and enterprise value of $4B.

Market Cap Evolution


Ashland's stock price is $53.26.

Ashland share price increased by 7.6% in the last year.

Ashland has an EPS (earnings per share) of $-18.45.

See more trading valuation data for Ashland
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4B$2B8.4%—-14.6%7.6%$-18.45

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Ashland Valuation Multiples

Ashland trades at 1.9x EV/Revenue multiple, and 9.0x EV/EBITDA.

See NTM and 2027E valuation multiples for Ashland

EV / Revenue (LTM)


Ashland Financial Valuation Multiples

As of May 1, 2026, Ashland has market cap of $2B and EV of $4B.

Ashland has a P/E ratio of 14.8x.

LTMLast FY202320242025202620272028
EV/Revenue1.9x2.0x1.6x1.8x2.0x
EV/EBITDA9.0x(7.0x)8.5x35.9x(7.0x)
EV/EBIT17.0x40.6x25.5x42.4x40.6x
EV/Gross Profit5.9x6.5x5.5x5.9x6.5x
P/E14.8x(2.9x)13.9x(28.9x)(2.9x)
EV/FCF24.9xn/m29.0x17.5xn/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Ashland Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Ashland Margins & Growth Rates

In the most recent fiscal year, Ashland reported gross margin of 30%, EBITDA margin of (28%), and net margin of (46%).

See estimated margins and future growth rates for Ashland

Ashland Margins

Last FY20242025202720282029
Gross Margin30%29%30%
EBITDA Margin(28%)5%(28%)
EBIT Margin5%4%5%
Net Margin(46%)(4%)(46%)
FCF Margin(0%)10%(0%)

Ashland Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(6%)(11%)
Gross Profit Growth(8%)(9%)
EBITDA Growth(76%)(614%)
EBIT Growth(40%)4%
Net Profit Growth(148%)900%
FCF Growth66%(102%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Ashland Operational KPIs

Ashland's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.2M for the same period.

Access forward-looking KPIs for Ashland
LTMLast FY202320242025202620272028
Rule of 4025%————
Bessemer Rule of X29%————
Revenue per Employee—$0.6M———
Opex per Employee—$0.2M———
G&A Expenses to Revenue—19%17%19%19%
R&D Expenses to Revenue3%3%2%3%3%
Opex to Revenue—25%24%25%25%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Ashland Competitors

Ashland competitors include Saudi Kayan, Huntsman, Quaker Houghton, Saudi Industrial Investment Group, Orbia, Ingevity, Zeon, Abu Qir Fertilizers, MOPCO and Turpaz Industries.

Most Ashland public comparables operate across Chemicals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Saudi Kayan2.1x2.1x24.3x17.9x
Huntsman0.7x0.7x12.4x14.1x
Quaker Houghton1.6x1.6x21.3x10.2x
Saudi Industrial Investment Group——(127.4x)(516.3x)
Orbia0.9x0.9x6.2x6.0x
Ingevity3.3x3.3x93.0x9.8x
Zeon0.7x0.8x5.9x6.4x
Abu Qir Fertilizers3.1x1.9x6.9x3.8x

This data is available for Pro users. Sign up to see all Ashland competitors and their valuation data.

Start Free Trial

Ashland M&A Activity

Ashland has acquired 3 companies to date.

Last acquisition by Ashland was on January 19th 2021. Ashland acquired Schülke & Mayr (personal care unit) for $284M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Ashland

Schülke & Mayr (personal care unit)
Pharmachem Laboratories
Oil Can Henry’s
Description
Schülke & Mayr personal care unit is a division of the Norderstedt-based Schülke & Mayr GmbH that manufactures and supplies disinfectants, antiseptics, preservatives, and biocides tailored for personal care formulations. Integrated within the broader Air Liquide-owned group since 2018, it focuses on skin-friendly antimicrobial agents used in hand sanitizers and body washes. The unit supports global personal care brands with products compliant to EU cosmetic regulations and supplies markets in Europe, Asia, and North America from German production facilities.
Pharmachem Laboratories is a New Jersey-based manufacturer and supplier of custom nutritional ingredients and process services. Serves natural products, food and beverage, and flavor and fragrance industries. Family of specialized divisions working together for integrated production capabilities.
Oil Can Henry’s is a Portland-headquartered chain of quick-lube service centers spanning Arizona, California, Colorado, Idaho, Minnesota, Oregon, and Washington. The company maintains 82 locations offering oil changes, fluid top-offs, and visual inspections without appointments. Oil Can Henry’s emphasizes eco-friendly practices with waste oil recycling programs. Founded in 1972, it expands through new builds in existing states, prioritizing customer convenience and technician training.
HQ CountryGermanyUnited StatesUnited States
HQ City
Norderstedt
Kearny, NJ
Portland, OR
Deal Date19 Jan 202117 Apr 20171 Feb 2016
Valuation$284M$660M$72M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Ashland acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Ashland

When was Ashland founded?Ashland was founded in 2016.
Where is Ashland headquartered?Ashland is headquartered in United States.
How many employees does Ashland have?As of today, Ashland has over 2K employees.
Who is the CEO of Ashland?Ashland's CEO is Guillermo Novo.
Is Ashland publicly listed?Yes, Ashland is a public company listed on NYSE.
What is the stock symbol of Ashland?Ashland trades under ASH ticker.
When did Ashland go public?Ashland went public in 1950.
Who are competitors of Ashland?Ashland main competitors include Saudi Kayan, Huntsman, Quaker Houghton, Saudi Industrial Investment Group, Orbia, Ingevity, Zeon, Abu Qir Fertilizers, MOPCO, Turpaz Industries.
What is the current market cap of Ashland?Ashland's current market cap is $2B.
What is the current revenue of Ashland?Ashland's last 12 months revenue is $2B.
What is the current revenue growth of Ashland?Ashland revenue growth (NTM/LTM) is 3%.
What is the current EV/Revenue multiple of Ashland?Current revenue multiple of Ashland is 1.9x.
Is Ashland profitable?Yes, Ashland is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Ashland?Ashland's last 12 months EBITDA is $396M.
What is Ashland's EBITDA margin?Ashland's last 12 months EBITDA margin is 22%.
What is the current EV/EBITDA multiple of Ashland?Current EBITDA multiple of Ashland is 9.0x.
What is the current FCF of Ashland?Ashland's last 12 months FCF is $143M.
What is Ashland's FCF margin?Ashland's last 12 months FCF margin is 8%.
What is the current EV/FCF multiple of Ashland?Current FCF multiple of Ashland is 24.9x.
How many companies Ashland has acquired to date?As of May 2026, Ashland has acquired 3 companies.
What was the largest acquisition by Ashland?$660M acquisition of Pharmachem Laboratories on 17th April 2017 was the largest M&A Ashland has done to date.
What companies Ashland acquired?Ashland acquired Pharmachem Laboratories, Schülke & Mayr (personal care unit), and Oil Can Henry’s.
In how many companies Ashland has invested to date?Ashland hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Ashland

Lists including Ashland

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial